After the tumors reached a size of 150 mm3, the anti-TFRC antibody or PBS (control) was intravenously injected twice per week for 3 weeks, and the tumor growth and weight were monitored at each time point (Fig.7A and B). This evidence concerns the gene TFRC and neoplasm.